{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:49:10Z","timestamp":1771490950739,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement"},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Molecular analyses have shown that tumours diagnosed as supratentorial primitive neuro-ectodermal tumours of the central nervous system (CNS-PNETs) in the past represent a heterogenous group of rare childhood tumours including high-grade gliomas (HGG), ependymomas, atypical teratoid\/rhabdoid tumours (AT\/RT), CNS neuroblastoma with forkhead box R2 (<jats:italic>FOXR2<\/jats:italic>) activation and embryonal tumour with multi-layered rosettes (ETMR). All these tumour types are rare and long-term clinical follow-up data are sparse. We retrospectively re-evaluated all children (0\u201318\u00a0years old) diagnosed with a CNS-PNET in Sweden during 1984\u20132015 and collected clinical data.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In total, 88 supratentorial CNS-PNETs were identified in the Swedish Childhood Cancer Registry and from these formalin-fixed paraffin-embedded tumour material was available for 71 patients. These tumours were histopathologically re-evaluated and, in addition, analysed using genome-wide DNA methylation profiling and classified by the MNP brain tumour classifier.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The most frequent tumour types, after histopathological re-evaluation, were HGG (35%) followed by AT\/RT (11%), CNS NB-<jats:italic>FOXR2<\/jats:italic> (10%) and ETMR (8%). DNA methylation profiling could further divide the tumours into specific subtypes and with a high accuracy classify these rare embryonal tumours. The 5 and 10-year overall survival (OS) for the whole CNS-PNET cohort was 45%\u2009\u00b1\u200912% and 42%\u2009\u00b1\u200912%, respectively. However, the different groups of tumour types identified after re-evaluation displayed very variable survival patterns, with a poor outcome for HGG and ETMR patients with 5-year OS 20%\u2009\u00b1\u200916% and 33%\u2009\u00b1\u200935%, respectively. On the contrary, high PFS and OS was observed for patients with CNS NB-<jats:italic>FOXR2<\/jats:italic> (5-year 100% for both). Survival rates remained stable even after 15-years of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings demonstrate, in a national based setting, the molecular heterogeneity of these tumours and show that DNA methylation profiling of these tumours provides an indispensable tool in distinguishing these rare tumours. Long-term follow-up data confirms previous findings with a favourable outcome for CNS NB-<jats:italic>FOXR2<\/jats:italic> tumours and poor chances of survival for ETMR and HGG<jats:italic>.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-023-01456-2","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T20:02:34Z","timestamp":1679515354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up"],"prefix":"10.1186","volume":"15","author":[{"given":"Elizabeth","family":"Schepke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"L\u00f6fgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresia","family":"Kling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Nordborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Olsson Bontell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"\u00d6berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Eliasson-Hofvander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Sabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Lannering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Car\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"issue":"5","key":"1456_CR1","first-page":"726","volume":"19","author":"AS Zhang","year":"2017","unstructured":"Zhang AS, et al. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010. Neuro Oncol. 2017;19(5):726\u201335.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11060-021-03927-z","volume":"156","author":"N Lamba","year":"2022","unstructured":"Lamba N, et al. The epidemiology of primary and metastatic brain tumors in infancy through childhood. J Neurooncol. 2022;156(2):419\u201329.","journal-title":"J Neurooncol"},{"key":"1456_CR3","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol. 2021;23:iii1\u2013105.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/j.1651-2227.2009.01417.x","volume":"98","author":"B Lannering","year":"2009","unstructured":"Lannering B, et al. Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984\u20132005. Acta Paediatr. 2009;98(10):1620\u20137.","journal-title":"Acta Paediatr"},{"issue":"1","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00165168","volume":"3","author":"CC Gaffney","year":"1985","unstructured":"Gaffney CC, et al. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neurooncol. 1985;3(1):23\u201333.","journal-title":"J Neurooncol"},{"key":"1456_CR6","doi-asserted-by":"crossref","unstructured":"Louis DN, Wiestler O, Cavenee WK, WHO classification of tomours of the central nervous system. 2007: Lyon: IARC, 2007.","DOI":"10.1007\/s00401-007-0278-6"},{"issue":"8","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ejca.2006.01.039","volume":"42","author":"BL Pizer","year":"2006","unstructured":"Pizer BL, et al. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP\/UKCCSG PNET 3 study. Eur J Cancer. 2006;42(8):1120\u20138.","journal-title":"Eur J Cancer"},{"key":"1456_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.4720","author":"EI Hwang","year":"2018","unstructured":"Hwang EI, et al. Extensive molecular and clinical hHeterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the children\u2019s oncology group randomized ACNS0332 Trial. J Clin Oncol. 2018. https:\/\/doi.org\/10.1200\/JCO.2017.76.4720.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1456_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.25405","volume":"62","author":"RI Jakacki","year":"2015","unstructured":"Jakacki RI, et al. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2015;62(5):776\u201383.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1456_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/0284186X.2017.1301679","volume":"56","author":"E Stensvold","year":"2017","unstructured":"Stensvold E, et al. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET)\u2014a retrospective analysis spanning 40 years of treatment. Acta Oncol. 2017;56(5):698\u2013705.","journal-title":"Acta Oncol"},{"issue":"8","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S1470-2045(12)70257-7","volume":"13","author":"D Picard","year":"2012","unstructured":"Picard D, et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol. 2012;13(8):838\u201348.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1456_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164(5):1060\u201372.","journal-title":"Cell"},{"issue":"6","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00401-013-1206-6","volume":"126","author":"EC Schwalbe","year":"2013","unstructured":"Schwalbe EC, et al. Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types. Acta Neuropathol. 2013;126(6):943\u20136.","journal-title":"Acta Neuropathol"},{"key":"1456_CR14","unstructured":"Louis DN et al, WHO Classification of Tumours of the Central Nervous System. 4th ed. 2016: International Agency for Research on Cancer (Lyon)."},{"key":"1456_CR15","unstructured":"Louis DN et al. WHO classification of tumours editorial board. Central nervous system tumours. 5th ed. 2021: International Agency for Research on Cancer (Lyon)."},{"issue":"6","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1148\/93.6.1351","volume":"93","author":"CH Chang","year":"1969","unstructured":"Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351\u20139.","journal-title":"Radiology"},{"issue":"6","key":"1456_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12838","volume":"48","author":"E Schepke","year":"2022","unstructured":"Schepke E, et al. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study. Neuropathol Appl Neurobiol. 2022;48(6): e12838.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"1456_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13148-021-01085-7","volume":"13","author":"S Ferreyra Vega","year":"2021","unstructured":"Ferreyra Vega S, et al. DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas. Clin Epigenetics. 2021;13(1):102.","journal-title":"Clin Epigenetics"},{"key":"1456_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469.","journal-title":"Nature"},{"key":"1456_CR20","unstructured":"Molecularneuropathology. Brain classifier 12.5. 2022."},{"key":"1456_CR21","unstructured":"Hovestedt, V. and M. Zapatka, conumee: Enhanced copy-number variation analysis using Illumina DNA methylation arrays, R package, Version 1.9.0."},{"key":"1456_CR22","unstructured":"R Core Team. R: A language and environment for statistical computing. 2022; https:\/\/www.R-project.org\/."},{"issue":"1","key":"1456_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-018-0630-1","volume":"6","author":"K Fukuoka","year":"2018","unstructured":"Fukuoka K, et al. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun. 2018;6(1):134.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"1456_CR24","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/neuonc\/noab136","volume":"23","author":"K von Hoff","year":"2021","unstructured":"von Hoff K, et al. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro Oncol. 2021;23(9):1597\u2013611.","journal-title":"Neuro Oncol"},{"key":"1456_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed. 2011;10:7.","journal-title":"J Negat Results Biomed"},{"issue":"3","key":"1456_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","volume":"120","author":"MJ van den Bent","year":"2010","unstructured":"van den Bent MJ. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective. Acta Neuropathol. 2010;120(3):297\u2013304.","journal-title":"Acta Neuropathol"},{"key":"1456_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac079.579","author":"M-K Keck","year":"2022","unstructured":"Keck M-K, et al. Amplification of the PLAG-family genes\u2014PLAGL1 and PLAGL2\u2014is\u00a0a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol. 2022. https:\/\/doi.org\/10.1093\/neuonc\/noac079.579.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1456_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018;136(2):181\u2013210.","journal-title":"Acta Neuropathol"},{"key":"1456_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab227","author":"Z Wu","year":"2021","unstructured":"Wu Z, et al. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Neuro Oncol. 2021. https:\/\/doi.org\/10.1093\/neuonc\/noab227.","journal-title":"Neuro Oncol"},{"key":"1456_CR30","unstructured":"Pickles JC et al, DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study. Lancet Child Adolesc Health, 2019."},{"issue":"11","key":"1456_CR31","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S2352-4642(21)00245-5","volume":"5","author":"S Khan","year":"2021","unstructured":"Khan S, et al. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a rare brain tumor registry study. Lancet Child Adolesc Health. 2021;5(11):800\u201313.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"1456_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/neuonc\/noab100","volume":"24","author":"BO Juhnke","year":"2022","unstructured":"Juhnke BO, et al. Treatment of embryonal tumors with multilayered rosettes with carboplatin\/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol. 2022;24(1):127\u201337.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1456_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00381-015-2920-2","volume":"32","author":"M Horwitz","year":"2016","unstructured":"Horwitz M, et al. Embryonal tumors with multilayered rosettes in children: the SFCE experience. Childs Nerv Syst. 2016;32(2):299\u2013305.","journal-title":"Childs Nerv Syst"},{"key":"1456_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02484-7","author":"APY Liu","year":"2022","unstructured":"Liu APY, et al. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children\u2019s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol. 2022. https:\/\/doi.org\/10.1007\/s00401-022-02484-7.","journal-title":"Acta Neuropathol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01456-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-023-01456-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-023-01456-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T20:02:46Z","timestamp":1679515366000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-023-01456-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1186\/s13148-023-01456-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional ethics committee in V\u00e4stra G\u00f6taland region in Sweden (Dnr 604-12, T581-15, T821-17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}